March 3, 2022 | Emilia Molimpakis, Healthcare transformation, Impetus Digital, Natalie Yeadon, Thymia, artificial intelligence, digital health, gamification, health assessment, mental health, neuropsychology
Dr. Emilia Molimpakis, CEO & Co-founder of Thymia, shares how their platform uses video games based on neuropsychology, alongside analyses of facial microexpressions and speech, to quickly, accurately, and objectively assess and monitor mental health conditions such as depression.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
It is no secret that Pharma (still) has a major diversity problem.
Tip #7 – How do you increase engagement during virtual events? Make it fun! ️ See all Top 10 tips: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/
Tip #6 – Individualizing a virtual event for your participants makes it more likely for them to attend and gain something valuable from the event. Learn how else you can…
Tip #5 – Do you want to increase engagement during virtual events? To allow deep-dives into new data, discuss gaps/needs, or brainstorm new ideas, moderated small-group breakout sessions and workshops…
Tip #4 – How do you plan the agenda for your virtual event? We suggest to invite participant input to build and personalize the engagement. Check out our full top…
Tip #3 – Keep it simple! Check our top 10 tips to increase engagement during virtual events: https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/
After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) face-to-face again, believing that’s what most KOLs want. It may…
Tip #2 – Are you team “”jump on a call”” or team “”just email me””? Instead of choosing just one, try using a combination of synchronous (real-time) and asynchronous (over-time,…
Roland Mattern, Director of Product Marketing at eSight Eyewear, shares how eSight’s technologies are being used to bring sight back to people living with central vision loss. He also discusses…
How Pharma can (and why they should) help bring caregivers to the forefront
